Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic
Fooling the Virus: The Fusion protein as Virus-Specific Therapeutic An ACE2 A fusion protein of ACE2 with an Immunogenic Component Project ID : 47-2020-10877
Summary of the technology
Fooling the Virus: The Fusion protein as Virus-Specific Therapeutic
An ACE2 A fusion protein of ACE2 with an Immunogenic Component
Project ID : 47-2020-10877
Description of the technology
VP, Business Development, Healthcare
HUJI, School of Medicine - IMRIC
Immunology and Cancer Research
Innovation Intermediary from United KingdomCovid-19 Innovation Challenges by Innoget
Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.
Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at firstname.lastname@example.org to list them.
Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.